Holder snapshot 7 signals
Share change
-5,925,479
Put/Call ratio
77%
SEC-reported price per share
$7.52
Number of holders
423
Value change
-$46,832,800
Number of buys
181
Open additional details 1 more signal available
Number of sells
153
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,148,777,709

Security key

881624209

Report period

Q2 2022

Institutions

423

Top holders

10

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $1,241,032,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors has the largest disclosed position value at $1.24B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Disclosed position value Top 5
Capital Research Global Investors $1.24B
BlackRock Finance, Inc. $391.08M
ABRAMS CAPITAL MANAGEMENT, L.P. $225.8M
MENORA MIVTACHIM HOLDINGS LTD. $218.89M
Migdal Insurance & Financial Hold... $195.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$1,241,032,000
132,165,515 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$391,081,000
41,648,716 shares
— 31 Mar 2022
ABRAMS CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$225,795,000
24,046,356 shares
— 31 Mar 2022
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
13F
—
denominator unverified
$218,887,000
23,310,610 shares
— 31 Mar 2022
Migdal Insurance & Financial Holdings Ltd.
13F
Company
13F
—
denominator unverified
$195,937,000
20,866,560 shares
— 31 Mar 2022
Clal Insurance Enterprises Holdings Ltd
13F
Company
13F
—
denominator unverified
$167,914,000
17,538,566 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
423
Shares
505,606,590
Rows available
423
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
420
Q2 2022 holders
423
Holder diff
3
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .